iXCells Biotechnologies Expands CRISPR-Cas9 Cell Products and Genome Engineering Services

Gene Editing Services Deliver Disease Relevant Cell Models to Improve Preclinical Drug Development SAN DIEGO -- iXCells Biotechnologies ("iXCells" or the "Company"), a provider of cell products and drug discovery services to the worldwide academic, biotech and pharmaceutical communities, today announced expansion of its CRISPR-Cas9 product and custom services offering, with special focus on induced [...]

iXCells Biotechnologies and Fujifilm Wako Announce Distribution Agreement

Expanding iXCells Global Footprint iXCells Biotechnologies USA, Inc. (San Diego, CA), a leading cell technology company specializing in preclinical drug discovery solutions, today announced it has entered into a distribution agreement with Fujifilm WAKO Pure Chemical Corp. (Osaka, JP), a provider of highly functional and high-quality laboratory reagents, primary and engineered cell products, specialty chemicals, [...]

Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology

MILFORD, Mass. -- Waters™ Corporation (NYSE:WAT) today announced it has completed its acquisition of Wyatt Technology, a pioneer and well-recognized leader in innovative light scattering and field-flow fractionation instruments, software, accessories, and services. With more than 80% of its rapidly growing revenues tied to large molecule applications, Wyatt accelerates Waters' ability to build a high-growth business [...]

Lonza Launches TheraPEAK® T-VIVO® Cell Culture Medium to Accelerate Cell Therapy Development

Lonza launches the TheraPEAK® T-VIVO® Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing Unlike other serum-free media, the medium does not require the addition of human serum or its components to achieve high performance By eliminating animal components, the medium improves performance, delivers greater consistency and [...]

Neutec Group Introduces the oCelloscope Automated Microbial Live-Cell Imaging technology, by Biosense Solutions

Neu-tec Group Inc, in North America, is pleased to announce its new distribution partnership with the DK based Biosense Solutions. The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development. It uniquely tracks the growth of microorganisms in multi-well plates by combining microscopic imaging with automated [...]

Datacolor acquires matchmycolor

Datacolor AG, a global leader in color management solutions, announces the acquisition of matchmycolor LLC, a technology company specialized in color formulation and communication software. Datacolor consolidates matchmycolor as of January 1, 2023. The costs for the acquisition and the integration will affect fiscal years 2022/23 and 2023/24. The strategic acquisition strengthens Datacolor’s market position [...]

Neutec Group Introduces the oCelloscope Automated Microbial Live-Cell Imaging technology, by Biosense Solutions

Neu-tec Group Inc, in North America, is pleased to announce its new distribution partnership with the DK based Biosense Solutions. The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development. It uniquely tracks the growth of microorganisms in multi-well plates by combining microscopic imaging with automated [...]

HTG Highlights the Advantages of Its Drug Discovery Engine

TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of another technical milestone in its drug discovery business. HTG is pioneering a proprietary platform-based approach that is designed to help improve drug discovery, referred to as transcriptome-informed drug discovery and design. HTG’s [...]

Efficient transduction of CAR into T-cells

AMSBIO announce a new range of high-titer Chimeric Antigen Receptor (CAR) lentivirus that provide high transduction efficiency with long-term, stable expression in resting and actively dividing cells. Personalized treatment for cancer reached a new milestone in 2017 with the FDA approval of CAR-T cells for treatment of leukemia and lymphoma. Consequently, there is now rapid growth in research [...]

Illumina’s genomic technologies enable better pathogen preparedness and response

SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today recognized the progress and impact of genomic technologies on pathogen preparedness and response. Following the boost in sequencing infrastructure and capabilities driven by the COVID-19 pandemic, today genomic technologies are enabling public health agencies and health care systems to [...]

Access IBO on Knowledge Center